BeBetter Medicine Technology Co., LTD. is a rapid growth novel drug discovery and development company located in Guangzhou, China. It was founded in 2012 by overseas returnees and aims to create advanced novel medicines to treat cancer and other severe diseases. The company has strong expertise and outstanding facilities to conduct comprehensive pharmaceutical research from drug design, synthesis to clinical development. Currently there are eight innovative drug candidates with own IP rights are in clinical or IND stages. Among them, BEBT-908 has entered the pivotal phase II trial for the treatment of lymphoma. BEBT-209 and BEBT-109 are in the phase Ib/II trial for the treatment of breast cancer and lung cancer, respectively. The company is expected to have a number of new drugs on the market in the next few years.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 8th Floor, No. 25, Yayingshi Road, Science City,luogang District,guangzhou,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://bebettermed.cn/
- HQ
- Science City, Luogang District, Guangzhou
Bebetter Med Questions
Bebetter Med's website is http://bebettermed.cn/
Bebetter Med's LinkedIn profile is https://cn.linkedin.com/company/bebetter-med
Bebetter Med has
5 employees.
View email and phone details for 5
employees at Bebetter Med.
Bebetter Med's industry is
Biotechnology Research
Bebetter Med's top competitors are
Formurex,
Pt. Infion Pharmaceutical Company,
Chaingen Bio,
Makeitskin,
4d Molecular Therapeutics,
Bernofarm,
Silence Therapeutics Plc,
Brothers Cairns,
Mercy Pharmacy Group,
Scpharmaceuticals.
Bebetter Med's categories are Biotechnology Research
Bebetter Med's founding year is 2012
